Business Standard

Here's why Mehul Kothari recommends buying Metropolis, Thyrocare Tech

According to the technical analyst from Anand Rathi, Metropolis Healthcare can rally to Rs 1,800, while Thyrocare Technologies can rise up to Rs 740.

technicals
Premium

technicals

Mehul Kothari Mumbai
BUY
Metropolis
Buy Near: Rs 1,500
Target: Rs 1,800
Stop Loss: Rs 1,350

Like other diagnostic stocks, even Metropolis Healthcare was under corrective mode since many months. In recent sessions, the stock has confirmed a higher top formation on the daily scale.

Also, we are witnessing a falling wedge breakout on the daily scale. Thus, we advise traders to buy the stock near Rs 1,500 for a target of Rs 1,800 in the coming sessions.

BUY
Thyrocare
Buy Near: Rs 680
Target: Rs 740
Stop Loss: Rs 650

Even Thyrocare Technologies was under a heavy corrective mode and now has confirmed higher top and higher bottom formation on the daily scale.

At this

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in